Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)
China flag China · Delayed Price · Currency is CNY
8.19
+0.08 (0.99%)
Sep 30, 2026, 3:00 PM CST

SHA:600613 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,8391,9522,0482,3402,3882,300
Other Revenue
0.320.620.510.680.222.92
1,8401,9522,0492,3412,3892,303
Revenue Growth
-3.14%-4.71%-12.48%-2.00%3.72%26.61%
Cost of Revenue
1,0571,0891,0971,1891,125918.13
Gross Profit
782.69863.82951.711,1521,2631,385
Selling, General & Admin
639.3718.19784.631,0021,0971,232
Research & Development
31.1130.2432.8932.345.9950.95
Other Operating Expenses
27.3325.9324.5826.5129.6227.22
Operating Expenses
716.99794.18858.281,0251,1781,294
Operating Income
65.769.6493.43126.3785.7990.69
Interest Expense
-6.6-10.07-12.8-14.76-17.37-8.34
Interest & Investment Income
8.7210.4310.855.978.1730.51
Currency Exchange Gain (Loss)
0.010.01-0.1200-0
Other Non Operating Income (Expenses)
-3.64-1.94-3.6211.79-13.916.17
EBT Excluding Unusual Items
64.1968.0887.74129.3762.69119.03
Impairment of Goodwill
----55.21--
Gain (Loss) on Sale of Investments
-3.780.55-0.020.9--
Gain (Loss) on Sale of Assets
0.270.22-0.370.17-5.23-0
Asset Writedown
---1.47-0.47-2.72-26.72
Other Unusual Items
1.832.031.78.668.497.29
Pretax Income
62.5270.8787.5883.4163.2399.6
Income Tax Expense
31.5931.0421.525.1514.9331.64
Earnings From Continuing Operations
30.9239.8466.0858.2648.2967.96
Minority Interest in Earnings
-3.52-1.595.31-1.260.251.66
Net Income
27.438.2471.395748.5569.62
Net Income to Common
27.438.2471.395748.5569.62
Net Income Growth
-58.71%-46.43%25.24%17.41%-30.27%-
Shares Outstanding (Basic)
548546549518539536
Shares Outstanding (Diluted)
548546549518539536
Shares Change
-0.86%-0.51%5.97%-3.94%0.72%0.46%
EPS (Basic)
0.050.070.130.110.090.13
EPS (Diluted)
0.050.070.130.110.090.13
EPS Growth
-58.35%-46.15%18.18%22.22%-30.77%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
154.0891.26171.39191.08292.5998.3
Free Cash Flow Per Share
0.280.170.310.370.540.18
Dividend Per Share
0.0700.0700.1500.1000.1000.100
Dividend Growth
-53.33%-53.33%50.00%0%0%-
Gross Margin
42.55%44.25%46.45%49.20%52.90%60.13%
Operating Margin
3.57%3.57%4.56%5.40%3.59%3.94%
Profit Margin
1.49%1.96%3.48%2.44%2.03%3.02%
Free Cash Flow Margin
8.38%4.67%8.37%8.16%12.25%4.27%
EBITDA
145.87143.97171.83207.57170.59147.2
EBITDA Margin
7.93%7.37%8.39%8.87%7.14%6.39%
D&A For EBITDA
80.1774.3378.4181.284.856.51
EBIT
65.769.6493.43126.3785.7990.69
EBIT Margin
3.57%3.57%4.56%5.40%3.59%3.94%
Effective Tax Rate
50.53%43.79%24.55%30.15%23.62%31.76%
Revenue as Reported
1,8401,9522,0492,3412,3892,303